A detailed history of Roxbury Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Roxbury Financial LLC holds 3,569 shares of ABBV stock, worth $835,146. This represents 0.73% of its overall portfolio holdings.

Number of Shares
3,569
Previous 3,549 0.56%
Holding current value
$835,146
Previous $822 Million 0.77%
% of portfolio
0.73%
Previous 0.76%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 05, 2026

BUY
$211.96 - $244.38 $4,239 - $4,887
20 Added 0.56%
3,569 $815 Million
Q3 2025

Oct 01, 2025

SELL
$184.85 - $231.54 $4,806 - $6,020
-26 Reduced 0.73%
3,549 $822 Million
Q2 2025

Jul 07, 2025

BUY
$170.16 - $206.27 $140,722 - $170,585
827 Added 30.09%
3,575 $664 Million
Q1 2025

Apr 09, 2025

BUY
$169.2 - $216.66 $6,091 - $7,799
36 Added 1.33%
2,748 $574 Million
Q4 2024

Jan 30, 2025

BUY
$164.99 - $203.87 $447,452 - $552,895
2,712 New
2,712 $496 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Roxbury Financial LLC Portfolio

Follow Roxbury Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roxbury Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roxbury Financial LLC with notifications on news.